People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anomali Inc | — | Other Technology | Series B | $40.0M | $1.2B | 2018 |
| Revolutionary Medical Devices, Inc. | — | Healthtech | Seed | $4.2M | $21.1M | 2016 |
TOM REILLY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TOM REILLY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| KARIM FARIS | 1 | 10 |
| Steve Herrod | 1 | 4 |
| David Kane | 1 | 3 |
| Paul Molloy | 1 | 3 |
| Steve Harrick | 1 | 3 |
| NICK SOLOWAY | 1 | 1 |
| Hugh Njemanze | 1 | 1 |
| Danielle M. Pedro | 1 | 1 |
| Michael M. Pedro | 1 | 1 |
| MICHAEL PEDRO | 1 | 1 |
| BRYAN WALSER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.